“…Therefore, it may affect the microenvironment of bone marrow and inhibit the generation and differentiation of pluripotent hematopoietic stem cells. The immunological reactions include the immunoglobulin (Ig) E-mediated hypersensitivity reaction, drug-induced IgG and IgM responses, and antineutrophil cytoplasm antibodies (ANCA) associated immune injury, which might contribute to agranulocytosis [1,7,[12][13]. Bone marrow characteristics may be valuable in revealing the tion of the 33 cases, there were 15 cases with bone marrow active proliferation, 3 cases with hyperplasia and 2 cases with hypoplasia in type I, while 3 cases with hyperplasia and 10 cases with active proliferation were indentified in type II.…”